We have used alanine scanning to analyze protein-protein interactions by human TATA-element binding protein (TBP) within the transcription preinitiation complex. The results indicate that TBP interacts with RNA polymerase II and general transcription factors IIA, IIB, and IIF within the functional transcription preinitiation complex and define the determinants of TBP for each of these interactions. The results permit construction of a model for the structure of the preinitiation complex.
Transcription initiation at eukaryotic protein-encoding genes is preceded by the assembly on promoter DNA of a preinitiation complex consisting of RNA polymerase II (Pol) and six general transcription factors (GTFs): i.e., IIA, IIB, IID, IIE, IIF, and IIH (1, 2) . The human preinitiation complex contains at least 35 distinct polypeptide chains (at least 10 in Pol and at least 25 in the six GTFs) and has a molecular mass in excess of 2 MDa. Understanding human transcription initiation and transcription regulation will require elucidation of the arrangement of these numerous polypeptide chains relative to promoter DNA and relative to each other.
The first step in assembly of the preinitiation complex is binding of IID to a specific DNA sequence-the TATA element-located upstream of the transcription start (1, 2) . IID is a multisubunit factor, consisting of the polypeptide chain responsible for recognition of the TATA element, termed TATA-element binding protein (TBP), and at least eight additional polypeptide chains, termed TBP-associated factors (TAFs) (1) (2) (3) (4) . TBP, by itself, is able to bind to promoter DNA in a sequence-specific fashion and to nucleate subsequent stepwise association of IIA, IIB, IIF-Pol, IIE, and IIH, yielding a preinitiation complex fully functional in basal transcription initiation (albeit not functional in activator-dependent transcription initiation.) TBP is thought to contain determinants for protein-protein interactions with Pol, GTFs, TAFs, and a number of transcription activators and repressors.
Within the past 2 years, the crystallographic structure of the yeast TBP-DNA complex has been determined to 2.5 A resolution, and the crystallographic structure of the Arabidopsis thaliana TBP-DNA complex has been determined to 1.9 A resolution (5, 6) . The conserved DNA-binding, GTF-binding, TAF-binding core domain of TBP consists of two 80-amino acid imperfect direct repeats. Each repeat consists of two a-helices and five (3-strands in the order 31-al-f32-f33-f4-f35-a2. The TBP-DNA complex is approximately twofold symmetric, with the first repeat responsible for recognition of the 3' half of the TATA element and with the second repeat responsible for recognition of the 5' half of the TATA element. TBP-DNA interactions are mediated through contacts between /31, ,B2, 133, 434, and ,Bs of the first and second repeats and
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the DNA minor groove. TBP sharply bends DNA in the TBP-DNA complex.
The availability of the crystallographic structure of the TBP-DNA complex makes possible a systematic structurefunction analysis of TBP-Pol, TBP-GTF, TBP-TAF, TBPactivator, and TBP-repressor interactions.
MATERIALS AND METHODS
Plasmids Encoding TBP Derivatives. Plasmid pHTT7fl-NH-TBP encodes 7 nonnative amino acids (MHHHHHH) followed by amino acids 2-339 of human TBP under control of the bacteriophage T7 gene 10 promoter. Plasmid pHTT7fl-NH-TBP was constructed by replacement of the EcoRI/ HindIII segment of plasmid pET21(+) (Novagen) by the EcoRI/HindIII segment of plasmid pTK590 (obtained from T. Kerppola and T. Curran). Site-directed mutagenesis (7) was used to construct plasmids encoding alanine-substituted TBP derivatives.
Preparation of TBP Derivatives. TBP derivatives were overproduced in transformants of Escherichia coli strain BL21(DE3) (Novagen), purified under denaturing conditions by metal ion affinity chromatography on Ni2+-NTA-agarose (Qiagen, Chatsworth, CA; procedure of the manufacturer, but with pH 5.75 in the third wash buffer), dialyzed 4 h at 4°C against two changes of 2000 vol of 8 M urea/100 mM sodium phosphate, pH 7.9/10 mM Tris-HCl/10 mM MgCl2/2 mM dithiothreitol/1 mM EDTA/0.2 mM EGTA/0.2 mM phenylmethylsulfonyl fluoride/0.1% Nonidet P-40 (NP-40), dialyzed 15 h at 4°C against two changes of 4000 vol of 20 mM Tris HCl, pH 7.9/100 mM KCl/10 mM MgCl2/2 mM dithiothreitol/1 mM EDTA/0.2 mM EGTA/0.2 mM phenylmethylsulfonyl fluoride/0.1% NP-40/10% glycerol, and desalted into 20 mM Hepes-NaOH, pH 7.9/100 mM KCl/1 mM dithiothreitol/0.1 mM EDTA/0.2 mM phenylmethylsulfonyl fluoride/10% glycerol on Sephadex G-25 DNA grade (Pharmacia). Typically, the yield was 0. 
RESULTS AND DISCUSSION
Alanine scanning-systematic construction of single-alanine substitutions and determination of effects on functionpermits identification of individual amino acid side-chain determinants for protein-protein interaction (17) (18) (19) (20) (21) (22) . Alanine scanning has two key advantages. First, alanine scanning yields a comprehensive set of substitutions, including both phenotypically positive and phenotypically negative substitutions. Second, and more important, alanine scanning yields sidechain truncation substitutions; alanine substitution eliminates all side-chain atoms beyond Cp.
In this work, we have used alanine scanning to analyze TBP-Pol and TBP-GTF interactions. Molecular modeling indicates that 81 nonproline amino acids of human TBP core domain have side-chain atoms beyond Cp accessible on the surface of the human TBP-DNA complex. We reason that these 81 amino acids constitute the entire set-or nearly the entire set-of amino acids of TBP that are candidates to make side-chain interactions with Pol and GTFs. For each of these 81 amino acids, we have constructed a single alanine substitution. We then have quantified the abilities of wild-type TBP and alanine-substituted TBP derivatives to interact successively with IIA, IIB, IIF, Pol, IIE, and IIH ( Figs. 1 and 2) .
Interaction with IIA. Alanine substitution of two-and only two-amino acids within human TBP core domain resulted in a .5-fold reduction in equilibrium binding constant for interaction with IIA; i.e., Glu-228 and Arg-235 ( Fig. 2A) . We conclude that for these two amino acids-and for no other amino acids of human TBP core domain-side-chain atoms beyond Cp are critical for interaction with IIA. In the structure of the TBP-DNA complex, amino acids 228 and 235 are located adjacent to each other on the same face of a2 of the first repeat of TBP and form a surface with dimensions of -6 A x -18 A (Fig. 3A) . We propose that amino acids 228 and 235 make direct contact with IIA in the TBP-DNA-IIA complex.
Our results confirm and extend reports that substitutions in and following a2 of the first repeat of yeast TBP affect interaction with IIA (26, 27) .
Interaction with IIB. Alanine substitution of three-and only three-amino acids within human TBP core domain resulted in a -5-fold reduction in equilibrium binding constant for interaction with IIB; i.e., Glu-284, Glu-286, and Leu-287 (Fig. 2B) . In vitro transcription experiments confirm that TBP derivatives having alanine substitutions at amino acid 284, amino acid 286, or amino acid 287 are defective in transcription initiation and that the defects can be overcome by excess IIB (Fig. 4A) . We conclude that for these three amino acids-and for no other amino acids of human TBP core domain-sidechain atoms beyond Cp are critical for interaction with IIB. In the structure of the TBP-DNA complex, amino acids 284, 286, and 287 are located immediately adjacent to each other in the 132-133 loop (the "stirrup") of the second repeat of TBP and form a surface with dimensions of -11 A x =16 A (Fig. 3B) .
We propose that amino acids 284, 286, and 287 make direct contact with IIB in the TBP-DNA-IIA-IIB complex.
Our results confirm and extend reports that a substitution in the 132-133 loop of the second repeat of yeast TBP (at the position equivalent to amino acid 287 of human TBP) affects interaction with IIB (28, 29) .
Interaction with IIF. Alanine substitution of one-and only one-amino acid within human TBP core domain resulted in a 25-fold reduction in equilibrium binding constant for interaction with IIF; i.e., Glu-320 (Fig. 2C) . The magnitude of the defect is modest, being only slightly greater than 5-fold. Nevertheless, the effect is real and reproducible. Furthermore, in vitro transcription experiments confirm that the TBP derivative having an alanine substitution at amino acid 320 is defective in transcription initiation (Fig. 4B) . We conclude that for amino acid 320-and for no other amino acid of human TBP core domain-side-chain atoms beyond Cp are critical for interaction with IIF.
In the structure of the TBP-DNA complex, amino acid 320 is located in a2 of the second repeat of TBP and forms a surface of -5 A x =7 A (Fig. 3C) . We propose that amino acid 320 makes direct contact with IIF in the TBP-DNA-IIA-IIB-IIF-Pol complex.
Alanine substitution of amino acid 327 resulted in a modest, but reproducible, reduction in interaction with IIF (=3-fold; Fig. 2C ). Amino acid 327 is located adjacent to amino acid 320 on the same face of a2 of the second repeat and may constitute an additional, energetically less significant, point of contact with IIF.
Interaction with Pol. Alanine substitution of two-and only two-amino acids within human TBP core domain resulted in a .5-fold reduction in equilibrium binding constant for interaction with Pol; i.e., Glu-206 and Leu-232 (Fig. 2D) . In vitro transcription experiments confirm that TBP derivatives having alanine substitutions at amino acid 206 or amino acid 232 are defective in transcription initiation (Fig. 4C) . We conclude that Interaction with TIE and IIH. Alanine substitution of no amino acid of human TBP core domain resulted in a .5-fold reduction in interaction with IIE or IIH (Figs. 2 E and F) . We conclude that for no amino acid of human TBP core domain are side-chain atoms beyond C, critical for interaction with IIE or IIH.
We propose that human TBP core domain makes no direct interactions with IIE and IIH within the preinitiation complex. However, we emphasize that this proposal must be considered tentative, since our analysis excludes proline atoms, side-chain Cp atoms, and backbone atoms, and since our threshold for significance of effects excludes atoms involved in weak or neutral interactions [interactions contributing less than 1 kcal/mol binding free energy (see legend to Fig. 2)] .
Structure of Preinitiation Complex. Our results permit construction of models of the successive higher-order complexes containing IIA, IIB, IIF, and Pol (Fig. 5) .
IIA consists of three distinct polypeptide chains with molecular masses of 14, 19, and 34 kDa (1, 2). Our results indicate that IIA interacts with the upstream face of TBP (Fig. SA) .
Published results indicate that IIA interacts with the DNA segment upstream of the TATA element (30) . Therefore, we model IIA interacting simultaneously with the upstream face of TBP and the upstream DNA segment (Fig. SA) .
IIB consists of a single polypeptide chain with a molecular mass of 35 kDa (1, 2) . The IIB core domain, which is sufficient for interaction with the TBP-promoter complex, consists of two 75-amino acid imperfect direct repeats (1, 2) . Our results indicate that IIB interacts with the underside of TBP (Fig. SA) . Therefore, we model IIB core domain interacting with the underside of TBP (Fig. 5B) (Fig. 5B) .
Pol consists of at least 10 distinct polypeptide chains and has a molecular mass in excess of 500 kDa (1, 2 (Fig. 3) . Both the small size of the determinants and the presence of only a small number of critical amino acid side chains in the determinants are reminiscent of patterns observed with functional epitopes for protein-antibody interaction, protein-receptor interaction, and prokaryotic transcription factor interactions (17) (18) (19) (20) (21) (22) . The small size of the determinants suggests that it may be possible to design low molecular weight mimics of the determinants for use as inhibitors of specific steps in transcription-complex assembly-inhibitors with applications as tools for molecular biology research and, potentially, with applications as therapeutic agents (see refs. 19 and 20) .
Although the determinants for protein-protein interaction defined in this work are small, there are four interacting factors, and the interacting factors are large. Therefore, the fraction of the surface of the TBP core domain screened by the interacting factors is large. This is especially true with respect to the first repeat of TBP core domain. According to the model in Fig. SB, virtually 
